East African Pharmaceutical Market, Forecast to 2021

  • ID: 4418535
  • Report
  • Region: Africa, East Africa
  • 106 Pages
  • Frost & Sullivan
1 of 4
Generic Pharmaceutical Products Continue to Dominate with Increased Foreign Direct Investment by Asian Manufacturers

FEATURED COMPANIES

  • AstraZeneca
  • Cadila
  • Denk
  • Medipharm
  • Ranbaxy
  • Shelys
  • MORE

Pharmaceutical markets in Sub-Saharan Africa are experiencing rapid growth as governments and healthcare providers battle with their respective burdens of disease. The continent has one of the highest burdens of disease, such as HIV, malaria, and tuberculosis, yet has limited healthcare resources and spending. As such there are great opportunities for growth in the pharmaceutical sector. While control and eradication of communicable diseases has been an ongoing priority area for governments, non-communicable diseases have now become an area of concern for the continent. This is driven by various factors that are mentioned in this study. In East Africa, the outlook of the healthcare environment is similar to that of the rest of Africa.

The countries generally share similar climate conditions, language, and disease prevalence. While significant strides have been made in healthcare provision, funding, infrastructure development and technology, the pharmaceutical sector in the region as a whole in East Africa is still much smaller than that of other regions in Africa, even though it has a higher population. Significant investments by multinational companies are driving growth using different proven business models.

The focus on universal healthcare, providing coverage for each citizen, particularly the poor and vulnerable, is a focal point for governments. With multiple participants in the region, including emerging leaders with high growth rates in the continent, pharmaceuticals in the region will now become more important than ever in the drive for better healthcare and the effort to meet millennium development goals. Some therapeutic areas in the countries under this study are now growing, giving an indication of future pharmaceutical opportunities.

The study covers the following pharmaceutical segments: cardiovascular, oncology, respiratory, anti-infective, and central nervous system.

Highlights of the report include:

  • Market overview and projections for the pharmaceutical market (2016-2021)
  • Revenue forecast and breakdown by therapeutic area
  • Revenue forecast by country and therapeutic segment analysis
  • Key trends, key participants, participant strategies, competitive environment analysis, and growth opportunities
  • Strategic recommendations and future outlook of pharmaceutical market

Key questions this study will answer include:

  • Is the East African pharmaceutical market growing? How long will it continue to grow and at what rate?
  • How is the East African pharmaceutical market structured and who are the key competitors in the market?
  • What are the drivers, restraints, and challenges of the East African pharmaceutical market?
  • How is the regulatory environment in the East African pharmaceutical market, and what is its future impact?
  • Who are the main stakeholders in the East African pharmaceutical market?
  • What are the growth opportunities in the East African pharmaceutical market?
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • AstraZeneca
  • Cadila
  • Denk
  • Medipharm
  • Ranbaxy
  • Shelys
  • MORE

1. Executive Summary

  • Key Findings
  • Scope and Segmentation
  • Key Questions this Study will Answer
  • Market Engineering Measurements
  • The Last Word - 3 Big Predictions

2. Market Overview

  • Market Overview - Segmentation
  • Market Overview - Global Market Perspective
  • Market Overview - Defining Healthcare Trends in the Future
  • Market Overview - New Market Opportunities

3. Drivers and Restraints - Total Pharmaceutical Market

  • Market Drivers
  • Drivers Explained
  • Market Restraints
  • Restraints Explained

4. Forecasts and Trends - Total Pharmaceutical Market

  • Market Engineering Measurements
  • Forecast Assumptions and Definitions
  • Revenue Forecast
  • Revenue Forecast Discussion
  • Percent Revenue Forecast by Country
  • Revenue Forecast by Country
  • Revenue Forecast by Country Discussion
  • Revenue Forecast by Therapeutic Segment
  • Revenue Forecast Discussion by Therapeutic Segments

5. Growth Opportunities and Companies to Action

  • Growth Opportunity 1 - Public - Private Partnerships
  • Growth Opportunity 2 - Regulatory Reform
  • Growth Opportunity 3 - API Manufacturing
  • Growth Opportunity 4 - Vaccines Manufacturing
  • Strategic Imperatives for Pharmaceutical Companies

6. Kenya Analysis

  • Kenya Overview
  • Kenya Healthcare Overview
  • Kenya Pharmaceutical Market Overview
  • Kenya Market Engineering Measurements
  • Kenya Revenue Forecast
  • Kenya Revenue Forecast by Therapeutic Segment
  • Kenya Revenue Forecast Discussion
  • Kenya Market Share Analysis
  • Kenya Competitive Environment
  • Kenya Competitive Environment Assessment

7. Tanzania Analysis

  • Tanzania Overview
  • Tanzania Healthcare Overview
  • Tanzania Pharmaceutical Market Overview
  • Tanzania Market Engineering Measurements
  • Tanzania Revenue Forecast
  • Tanzania Revenue Forecast by Therapeutic Segment
  • Tanzania Revenue Forecast Discussion
  • Tanzania Market Share Analysis
  • Tanzania Competitive Environment
  • Tanzania Competitive Environment Assessment

8. Ethiopia Analysis

  • Ethiopia Overview
  • Ethiopia Healthcare Overview
  • Ethiopia Pharmaceutical Market Overview
  • Ethiopia Market Engineering Measurements
  • Ethiopia Revenue Forecast
  • Ethiopia Revenue Forecast by Therapeutic Segment
  • Ethiopia Revenue Forecast Discussion
  • Ethiopia Market Share Analysis
  • Ethiopia Competitive Environment
  • Ethiopia Competitive Environment Assessment

9. Uganda Analysis

  • Uganda Overview
  • Uganda Healthcare Overview
  • Uganda Pharmaceutical Market Overview
  • Uganda Market Engineering Measurements
  • Uganda Revenue Forecast
  • Uganda Revenue Forecast by Therapeutic Segment
  • Uganda Revenue Forecast Discussion
  • Uganda Market Share Analysis
  • Uganda Competitive Environment
  • Uganda Competitive Environment Assessment

10. Rwanda Analysis

  • Rwanda Overview
  • Rwanda Healthcare Overview
  • Rwanda Pharmaceutical Market Overview
  • Rwanda Market Engineering Measurements
  • Rwanda Revenue Forecast
  • Rwanda Revenue Forecast by Therapeutic Segment
  • Rwanda Revenue Forecast Discussion
  • Rwanda Market Share Analysis
  • Rwanda Competitive Environment
  • Rwanda Competitive Environment Assessment

11. The Last Word

  • The Last Word - 3 Big Predictions
  • The Last Word - Discussion
  • Legal Disclaimer

12. Appendix

  • Market Engineering Methodology
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • AstraZeneca
  • Bayer
  • Bilim
  • Biodeal
  • CSPC
  • Cadila
  • Cipla
  • Cosmos
  • Denk
  • GSK
  • Julphar
  • Kampala Pharmaceutical Industries
  • Lab and Allied
  • Medipharm
  • Merck
  • Novartis
  • Pfizer
  • Ranbaxy
  • Regal
  • Roche
  • Sandoz
  • Shelys
  • Shreechem
  • Sterop
  • Universal
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll